F
FutureFuel Corp.
FFCIK 0001337298NYSEAcceleratedSmaller ReportingIndustrial Organic ChemicalsDelawareFY ends Dec 31
Period
FY 2025
Revenue
$95.74M
Net Income
$-49.40M
Total Assets
$192.24M
Equity
$154.71M
Shares Out
43.86M
Op. Cash Flow
$-28.73M
Business
FutureFuel Corp. manufactures diversified chemical products and bio-based fuel and specialty chemical products. It produces biodiesel (B100 and multiple blends), petrodiesel blends, crude and refined glycerin, custom specialty chemicals (including biocide intermediates, specialty polymers, dyes, stabilizers and oilfield chemicals) and performance chemicals such as polymer modifiers, surfactants and solvents. The company operates through two segments: chemicals (custom manufacturing and performance chemicals) and biofuels. It markets and distributes primarily within the United States by truck, rail and barge and also serves regional, national and global specialty customers.
Summary from filing dated 2025-03-31
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 96 | 243 | 368 | 396 | 321 | |
| Gross (loss) profit | −39 | 20 | 41 | 29 | 24 | |
| Compensation expense | 6 | 5 | 5 | 4 | 3 | |
| Other expense | 3 | 4 | 4 | 4 | 4 | |
| Related party expense | 674,000 | 632,000 | 616,000 | 611,000 | 649,000 | |
| Research and development expenses | 4 | 4 | 4 | 3 | 3 | |
| Total operating expenses | 14 | 13 | 14 | 11 | 11 | |
| (Loss) income from operations | −53 | 6 | 27 | 18 | 13 | |
| Interest and dividend income | 4 | 8 | 10 | 5 | 3 | |
| Interest expense | −153,000 | −138,000 | −138,000 | −128,000 | — | |
| Gain on marketable securities | 0 | 0 | 575,000 | −9 | −70,000 | |
| Other income, net | 0 | 2 | 1,000 | −4,000 | 114,000 | |
| Other income | 4 | 10 | 10 | −4 | 3 | |
| (Loss) income before income taxes | −49 | 16 | 37 | 14 | 16 | |
| Income tax provision | 165,000 | 792,000 | 1,000 | −1 | −10 | |
| Net (loss) income | −49 | 16 | 37 | 15 | 26 | |
| Basic (in dollars per share) | −1.13 | 0.35 | 0.85 | 0.35 | 0.6 | |
| Diluted (in dollars per share) | −1.13 | 0.35 | 0.85 | 0.35 | 0.6 | |
| Basic (in shares) | 44 | 44 | 44 | 44 | 44 | |
| Diluted (in shares) | 44 | 44 | 44 | 44 | 44 | |
| Other comprehensive income (loss) from unrealized net losses on available-for- sale debt securities | 0 | 0 | 2,000 | −227,000 | −38,000 | |
| Income tax effect | 0 | 0 | −1,000 | 48,000 | 8,000 | |
| Total unrealized gain (loss), net of tax | 0 | 0 | 1,000 | −179,000 | −30,000 | |
| Comprehensive (loss) income | −49 | 16 | 37 | 15 | 26 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 51 | 110 | 219 | 176 | 138 | |
| Accounts receivable, inclusive of the blenders tax credit of $0 and $6,683, and net of allowances for credit losses of $28 and $29, respectively | 9 | 22 | 28 | 26 | 29 | |
| Inventory, net | 21 | 21 | 25 | 27 | 27 | |
| Income tax receivable | 88,000 | 53,000 | 2 | 2 | 10 | |
| Other current assets | 14 | 9 | 11 | 2 | 1 | |
| Total current assets | 101 | 165 | 291 | 274 | 256 | |
| Property, plant and equipment, net | 87 | 79 | 73 | 77 | 83 | |
| Other noncurrent assets | 5 | 4 | 4 | 5 | 6 | |
| Total noncurrent assets | 92 | 83 | 77 | 82 | 88 | |
| Total Assets | 192 | 248 | 367 | 356 | 344 | |
| Deferred revenue current | 2 | 904,000 | 4 | — | — | |
| Dividends payable-current | 3 | 11 | 11 | 11 | 0 | |
| Accrued expenses and other current liabilities | 3 | 11 | 5 | 5 | 6 | |
| Total current liabilities | 18 | 33 | 41 | 56 | 35 | |
| Deferred revenue noncurrent | 14 | 6 | 13 | — | — | |
| Dividends payable -noncurrent | 196,000 | 0 | — | — | — | |
| Noncurrent deferred income taxes | 910,000 | 773,000 | 0 | 0 | 2 | |
| Other noncurrent liabilities | 4 | 1 | 3 | 2 | 2 | |
| Total noncurrent liabilities | 20 | 9 | 16 | 17 | 20 | |
| Total liabilities | 38 | 42 | 57 | 73 | 55 | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,863,507 and 43,803,243 issued and outstanding as of December 31, 2025 and 2024, respectively | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | |
| Additional paid in capital | 204 | 205 | 282 | 282 | 282 | |
| Retained earnings (accumulated deficit) | −49 | 383,000 | 27 | 508,000 | 6 | |
| Total stockholders equity | 155 | 206 | 310 | 283 | 289 | |
| Total Liabilities and Stockholders Equity | 192 | 248 | 367 | 356 | 344 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation | 10 | 9 | 10 | 10 | 10 | |
| Amortization of deferred financing costs | 82,000 | 103,000 | 101,000 | 95,000 | 95,000 | |
| (Benefit) provision for deferred income taxes | 137,000 | 773,000 | 0 | −2 | −10 | |
| Change in fair value of equity securities | 0 | 0 | −3 | 8 | 904,000 | |
| Change in fair value of derivative instruments | −221,000 | 2 | −2 | −343,000 | 609,000 | |
| Loss on the sale of investments | 0 | 0 | 3 | 248,000 | −834,000 | |
| Stock based compensation | 1 | 359,000 | 0 | 46,000 | 0 | |
| (Gain) loss on disposal of property, plant, and equipment | −34,000 | 30,000 | 29,000 | 64,000 | 11,000 | |
| Noncash interest expense | 36,000 | 35,000 | 34,000 | 33,000 | 32,000 | |
| Accounts receivable | 12 | 7 | −2 | 3 | −8 | |
| Accounts receivable related parties | 0 | 1,000 | 5,000 | 52,000 | 1 | |
| Inventory | −611,000 | 5 | −4 | 1 | 7 | |
| Income tax receivable | −35,000 | 2 | 19,000 | 8 | 8 | |
| Prepaid expenses | −99,000 | 380,000 | −652,000 | −106,000 | 379,000 | |
| Other assets | −4 | −146,000 | −935,000 | −144,000 | 732,000 | |
| Accounts payable | −519,000 | −12 | −6 | 14 | 2 | |
| Accounts payable related parties | −99,000 | 97,000 | −8 | −112,000 | 7 | |
| Dividends payable | 47,000 | 186,000 | 0 | 0 | — | |
| Accrued expenses and other current liabilities | −9 | 6 | −720,000 | −948,000 | 870,000 | |
| Deferred revenue | 9 | −9 | −2 | −4 | −3 | |
| Other noncurrent liabilities | 3 | −2 | 1 | −325,000 | −686,000 | |
| Net cash (used in) provided by operating activities | −29 | 25 | 21 | 52 | 44 | |
| Collateralization of derivative instruments | −1 | −132,000 | 1 | −404,000 | −750,000 | |
| Proceeds from the sale of marketable securities | 0 | 0 | 38 | 1 | 41 | |
| Proceeds from the sale of property, plant, and equipment | 34,000 | 6,000 | 0 | 61,000 | 0 | |
| Capital expenditures | −17 | −15 | −6 | −5 | −1 | |
| Net cash (used in) provided by investing activities | −19 | −15 | 33 | −4 | 15 | |
| Deferred financing costs | −376,000 | 0 | −14,000 | 0 | 0 | |
| Payment of dividends | −11 | −120 | −11 | −11 | −120 | |
| Net cash used in financing activities | −11 | −120 | −11 | −11 | −120 | |
| Net change in cash and cash equivalents | −58 | −110 | 44 | 38 | −61 | |
| Cash paid for interest | 71,000 | 0 | 0 | 3,000 | 47,000 | |
| Cash paid for income taxes | 27,000 | 457,000 | 20,000 | 69,000 | 83,000 | |
| Noncash capital expenditures included in accounts payable | 669,000 | 403,000 | 333,000 | 208,000 | 364,000 | |
| Dividends payable | 3 | 11 | 11 | — | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro